SCHEMBL613688

SCHEMBL613688

C[Si](C)(C)C#Cc1ccc(Br)cc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
CYP2A6 P11509 1/20 0.38
ALDH1A1 P00352 2/20 0.36
ACACB O00763 1/20 0.34
GABRA1 P14867 2/20 0.34
GABRG2 P18507 2/20 0.34
GABRB3 P28472 2/20 0.34
GABRA5 P31644 2/20 0.34
GABRA3 P34903 2/20 0.34
GABRA2 P47869 2/20 0.34
ADK P55263 1/20 0.33
PYCR1 P32322 1/20 0.33
NOS1 P29475 2/20 0.32
ALOX15 P16050 2/20 0.31
MAPK1 P28482 1/20 0.31
GRM5 P41594 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15977881 0.98 MAOA (0.38) MAOAMAOBCYP2A6ALDH1A1ACACB
SCHEMBL17934728 0.88 ADK (0.37) MAOAMAOBGABRA1GABRG2GABRB3
SCHEMBL1306384 0.87 GABRA1 (0.38) ALDH1A1GABRA1GABRG2GABRB3GABRA5
SCHEMBL1306505 0.85 APP (0.41) ALDH1A1GABRA1GABRG2GABRB3GABRA5
SCHEMBL2854252 0.80 CYP1A1 (0.44) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL440124 0.78 GRM5 (0.50) CYP2A6ALDH1A1GABRA1GABRG2GABRB3
SCHEMBL19174201 0.78 CYP1A1 (0.48) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL1093858 0.77 MAPK1 (0.33) MAOAMAOBACACBMAPK1
SCHEMBL3347257 0.76 GRM5 (0.48) MAOAMAOBCYP2A6ACACBGABRA1
SCHEMBL1230907 0.76 APP (0.48) ALDH1A1GABRA1GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112876861-B Preparation method of ZnO graft modified anti-aging polycarbonate engineering plastic 苏州耐特福材料科技有限公司 2022-05-20 CN claimed
CN-112876861-A Preparation method of ZnO graft modified anti-aging polycarbonate engineering plastic 深圳市华创汇能技术有限公司 2021-06-01 CN claimed
CN-109370266-B Modified carbon nano tube and preparation method and application thereof 吉林师范大学 2020-08-07 CN claimed
CN-109370266-A A kind of modified carbon nano-tube and its preparation method and application 吉林师范大学 2019-02-22 CN claimed
US-9200121-B2 Thermosetting poly(siloxane-diphenylbutadiyne) with readily tunable glass transition temperature and high thermal stability THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2015-12-01 US claimed
US-20150057421-A1 THERMOSETTING POLY(SILOXANE-DIPHENYLBUTADIYNE) WITH READILY TUNABLE GLASS TRANSITION TEMPERATURE AND HIGH THERMAL STABILITY THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2015-02-26 US claimed
WO-2013152619-A1 THERMOSETTING POLY(SILOXANE-DIPHENYLBUTADIYNE) WITH READILY TUNABLE GLASS TRANSITION TEMPERATURE AND HIGH THERMAL STABILITY THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2013-10-17 WO claimed
CN-117715912-B Macrocyclic ligands with picolinate groups, complexes thereof and medical uses 法国加柏公司 2026-05-12 CN disclosed
US-20260053393-A1 NEAR-IR GLUCOSE SENSORS PROFUSA INC (US) 2026-02-26 US disclosed
US-20260028554-A1 FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES OSMO LABS PBC (US) 2026-01-29 US disclosed
EP-4377316-B1 MACROCYCLIC LIGANDS WITH PICOLINATE GROUP(S), COMPLEXES THEREOF AND MEDICAL USES THEREOF GUERBET SA (FR) 2025-12-03 EP disclosed
EP-4631940-A1 COMPOUND TARGETING PAN-KRAS PROTEIN DEGRADATION AGENT AND USE THEREOF Betta Pharmaceuticals Co., Ltd. (CN) 2025-10-15 EP disclosed
US-20250230174-A1 NEAR-IR GLUCOSE SENSORS PROFUSA, INC. (US) 2025-07-17 US disclosed
EP-0471612-A2 New steroids having an amide substituted group in the 11-beta position, their preparation, their use as medicines and pharmaceutical composition thereof ROUSSEL UCLAF (FR) 1992-02-19 EP disclosed
EP-0384842-A1 19-Nor steroids substituted at position 11-beta by a hydrocarbon chain containing an amide or carbamate group, their preparation, intermediates, their use as medicaments and pharmaceutical compositions containing them ROUSSEL-UCLAF (FR) 1990-08-29 EP disclosed
US-4912097-A Novel 11 β-alkynylphenyl-10-nor-steroids ROUSSEL UCLAF (FR) 1990-03-27 US disclosed
EP-0245170-B1 19-NOR OR 19-NOR D-HOMO STEROIDS SUBSTITUTED AT POSITION 11 BETA BY A PHENYL GROUP SUBSTITUTED BY AN ALKYNYL GROUP, PROCESS FOR THEIR PREPARATION, THEIR USE IN MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1989-11-29 EP disclosed
EP-0245170-A1 19-Nor or 19-nor D-homo steroids substituted at position 11 beta by a phenyl group substituted by an alkynyl group, process for their preparation, their use in medicaments and pharmaceutical compositions containing them ROUSSEL-UCLAF (FR) 1987-11-11 EP disclosed
US-4497951-A Ethynyl-phenylene-substituted-1,3,5-triazine derivatives and process for their production HUGHES AIRCRAFT COMPANY (US) 1985-02-05 US disclosed
US-4442278-A Ethynyl-substituted s-triazine derivatives, polymers thereof and process for making the same HUGHES AIRCRAFT COMPANY (US) 1984-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250230174-A1 NEAR-IR GLUCOSE SENSORS IRS1, INSR, SLC2A4 MAOA 4435/4885MAOB 4480/4885CYP2A6 4399/4885
US-20260053393-A1 NEAR-IR GLUCOSE SENSORS INSR, IRS1, SLC2A4 MAOA 4418/4885MAOB 4384/4885CYP2A6 2907/4885
US-20260028554-A1 FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES TAS2R42, TAS2R4, TAS2R41 MAOA 783/4885MAOB 1346/4885CYP2A6 535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.